Related Experiment Video
Updated: Mar 17, 2026

Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
Main-chain degradable single-chain cyclized polymers as gene delivery vectors
Yongsheng Gao1, Verena I Böhmer2, Dezhong Zhou1
1Charles Institute of Dermatology, School of Medicine and Medical Science, University College Dublin, Belfield, Dublin 4, Ireland.
Researchers developed degradable single-chain polymeric nanoparticles using a novel one-pot method. These nanoparticles show promise for gene delivery, offering high transfection efficiency and low toxicity in cellular studies.
Area of Science:
- Polymer Chemistry
- Nanotechnology
- Biomedical Engineering
Background:
- Single-chain technology (SCT) enables nanoscale polymer object fabrication but faces limitations in biological applications due to non-degradable backbones and scalability issues.
- Current SCT methods often use vinyl monomers, resulting in persistent carbon-carbon backbones unsuitable for biomedical use.
- Ultrahigh dilution conditions required for synthesis hinder large-scale production of single-chain polymer nanoparticles.
Purpose of the Study:
- To develop a versatile approach for creating backbone-degradable single-chain polymeric nanoparticles.
- To overcome the limitations of non-degradable backbones and ultrahigh dilution conditions in SCT.
- To evaluate the gene transfection capabilities and cytotoxicity of the novel degradable nanoparticles.
Main Methods:
- A one-pot RAFT copolymerization combining ring-opening addition polymerization and intramolecular cyclization was employed.
- Kinetic control and statistical manipulation of mono- and multi-vinyl monomer copolymerization facilitated in situ intramolecular cyclization.
- A cyclic allylsulfide monomer (MDTD) was used to introduce disulfide groups for backbone degradability.
Main Results:
- Backbone degradable single-chain polymeric nanoparticles were successfully synthesized under concentrated conditions.
- The nanoparticles achieved molecular weights of 10 kDa with 4.7% MDTD incorporation.
- Chemical degradation confirmed the single-chain nature and backbone degradability of the nanoparticles.
- The nanoparticles exhibited high gene transfection efficiencies and low cytotoxicities in 3T3 and HeLa cells.
Conclusions:
- A novel, scalable method for producing backbone-degradable single-chain polymeric nanoparticles was established.
- The developed nanoparticles are suitable for biomedical applications, particularly gene delivery.
- The findings pave the way for advanced nanomedicine applications utilizing degradable polymeric nanostructures.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Gene Therapy

